West Virginia University Logo

Disease Site: Blood and Marrow Transplant

1 protocol(s) meet the specified criteria

  • BMTCTN1102A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Age 50 or Older with Intermediate-2 and High Risk Myelodysplastic Syndrome